Who Paid My Doc
Phase I SRD
Research payments
$124,439
Through program year 2022, $124,439 in research payments was reported against Phase I SRD, across 285 payments, paid by Boehringer Ingelheim Pharma GmbH & Co.KG.
- Paid by
- Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $22,517 | 6 |
| 2021 | Research | $26,443 | 62 |
| 2020 | Research | $68,277 | 160 |
| 2019 | Research | $7,203 | 57 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Randolph Winter Haven, FL Named on 45 payments
- David Brown Houston, TX Named on 40 payments
- Sunil Patel Abilene, TX Named on 33 payments
- William Bridges Asheville, NC Named on 32 payments
- Sunir Garg Plymouth Meeting, PA Named on 30 payments
- Dennis Marcus Augusta, GA Named on 29 payments
- Sunil Gupta Pensacola, FL Named on 28 payments
- David Boyer Los Angeles, CA Named on 25 payments
- Nauman Chaudhry Waterford, CT Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.